Enimmune corporation (TPEX:6564)
Taiwan · Delayed Price · Currency is TWD 20.85
+0.35 (1.71%)
Jan 22, 2026, 2:07 PM CST
Enimmune corporation Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -164.74 | -157.55 | -223.74 | -247.96 | -47.25 | -74.45 | Upgrade |
Depreciation & Amortization | 7.83 | 7.44 | 7.6 | 8.2 | 8.49 | 6.95 | Upgrade |
Other Amortization | 0.15 | 0.15 | 0.15 | 0.15 | 0.14 | 0.03 | Upgrade |
Stock-Based Compensation | 2.49 | 3.03 | 3.69 | 2.27 | - | 0.12 | Upgrade |
Provision & Write-off of Bad Debts | -1.57 | -0.15 | 0.17 | 4.92 | 0.07 | - | Upgrade |
Other Operating Activities | -20.35 | 9.31 | -13.89 | -19.33 | 0.02 | 0.02 | Upgrade |
Change in Accounts Receivable | 8.55 | -0.45 | -7.47 | 17.46 | 1.19 | -22.92 | Upgrade |
Change in Inventory | -28.34 | -6.64 | 44.78 | -8.48 | -9.79 | -42.05 | Upgrade |
Change in Accounts Payable | 8.62 | -15.17 | 14.09 | -6.39 | -6.75 | 17.11 | Upgrade |
Change in Unearned Revenue | - | - | - | - | 1.72 | - | Upgrade |
Change in Other Net Operating Assets | 20.47 | 16.24 | 36.5 | 48.53 | -19.38 | 7.79 | Upgrade |
Operating Cash Flow | -166.89 | -143.78 | -138.13 | -200.64 | -71.55 | -107.42 | Upgrade |
Capital Expenditures | -1.52 | -0.47 | - | -0.35 | -2.98 | -4.19 | Upgrade |
Sale (Purchase) of Intangibles | - | - | - | - | -0.43 | -0.33 | Upgrade |
Investment in Securities | 18 | - | 88 | 123.49 | 93.5 | -281.4 | Upgrade |
Other Investing Activities | 0.07 | -3.17 | -0.14 | -23.21 | 0.01 | -0.92 | Upgrade |
Investing Cash Flow | 16.55 | -3.64 | 87.86 | 99.94 | 90.1 | -286.84 | Upgrade |
Short-Term Debt Issued | - | 60 | 20 | 20 | - | - | Upgrade |
Long-Term Debt Issued | - | 6.11 | - | - | - | 10.5 | Upgrade |
Total Debt Issued | 59.78 | 66.11 | 20 | 20 | - | 10.5 | Upgrade |
Long-Term Debt Repaid | - | -4.06 | -3.97 | -3.95 | -3.94 | -2.79 | Upgrade |
Net Debt Issued (Repaid) | 53.76 | 62.05 | 16.03 | 16.05 | -3.94 | 7.71 | Upgrade |
Issuance of Common Stock | 2.06 | 202.04 | - | 220.35 | - | 367.94 | Upgrade |
Other Financing Activities | -156.31 | - | - | 144.68 | - | - | Upgrade |
Financing Cash Flow | -100.49 | 264.09 | 16.03 | 381.08 | -3.94 | 375.66 | Upgrade |
Foreign Exchange Rate Adjustments | -6.13 | 8.34 | -0.04 | -4.59 | - | - | Upgrade |
Net Cash Flow | -256.95 | 125.01 | -34.28 | 275.79 | 14.61 | -18.6 | Upgrade |
Free Cash Flow | -168.41 | -144.25 | -138.13 | -200.98 | -74.53 | -111.61 | Upgrade |
Free Cash Flow Margin | -398.77% | -361.39% | -317.59% | -106.67% | -67.86% | -487.89% | Upgrade |
Free Cash Flow Per Share | -2.27 | -2.02 | -2.10 | -3.15 | -1.24 | -2.09 | Upgrade |
Cash Interest Paid | 2.99 | 2.12 | 0.92 | 0.28 | 0.21 | 0.16 | Upgrade |
Levered Free Cash Flow | -125.11 | -74.54 | -53.27 | -127.9 | -61.94 | -91.91 | Upgrade |
Unlevered Free Cash Flow | -123.21 | -73.16 | -52.65 | -127.7 | -61.79 | -91.8 | Upgrade |
Change in Working Capital | 9.3 | -6.02 | 87.9 | 51.12 | -33.01 | -40.08 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.